Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood
Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood
This is a Randomized double blind trial with the aim to estimate the effectiveness of 3
 therapeutic regimes per os on migraine pain:

 -  metoclopramide 0,15 mg/kg + placebo

 -  metoclopramide 0,15 mg/Kg + ketoprofen 1 mg/kg

 -  ketoprofen 1 mg/Kg + placebo

 Intensity of pain will be measured with linear 1-10 scale or analogic McGrath type scale
 every 20 min.

 The main objective is the evaluation of healing times from pain in the 3 groups
Inclusion Criteria:

 -  Children 6-17 years old with migraine presenting in emergency room

 Exclusion Criteria:

 -  Informed consensus not obtained

 -  Occurring migraine still treated

 -  Hemiplegic migraine